Table 2: Joanna Briggs Institute critical appraisal checklist for randomised clinical trials.

Article

Q1

Q2

Q3

Q4

Q5

Q6

Q7

Q8

Q9

Q10

Q11

Q12

Q13

Score

Cremascoli, et al. [30]

Y

Y

Y

N

Y

Y

Y

Y

N

Y

N

N

Y

9/13 (69.2%)

Figueiro, et al. [31]

Y

N

U

N

Y

Y

Y

Y

N

Y

N

N

Y

7/13 (53.8%)

Kim, et al. [34]

Y

N

Y

U

U

Y

U

Y

N

Y

N

Y

Y

7/13 (53.8%)

Cibeira, et al. [29]

U

N

N

N

N

N

N

N

N

N

N

Y

N

1/13

(7.69%)

Hjetland, et al. [32]

Y

N

Y

N

Y

Y

Y

Y

N

Y

N

Y

Y

9/13 (69.2%)

Kolberg, et al. [25]

Y

N

Y

N

Y

Y

Y

Y

N

Y

N

Y

Y

10/13 (76.9%)

Kolberg, et al. [20]

Y

N

Y

N

Y

Y

Y

Y

Y

Y

N

Y

Y

9/13 (69.2%)

Bromundt, et al. [28]

N

N

Y

N

N

N

N

Y

N

Y

N

N

N

3/13 (23%)

Kheradmand, et al. [33]

Y

Y

Y

U

U

Y

U

Y

N

Y

U

N

Y

7/13

(53.8%)

Note: Q1: Randomization; Q2: Concealed allocation; Q3: Groups similar at baseline; Q4: Participants blinded; Q5: Allocator blinded; Q6: Treatment Groups treated equally; Q7: Assessors blinded; Q8: Outcomes measured in the same way in groups; Q9: Outcomes measured reliably; Q10: Follow-up complete; Q11: Participants analysed in original group; Q12: Appropriate statistical analysis; Q13: Appropriate trial design. Abbreviations: Y: Yes; N: No; U: Unclear; N/A: not applicable